Skip to main content

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.

Publication ,  Journal Article
Bevers, TB; Niell, BL; Baker, JL; Bennett, DL; Bonaccio, E; Camp, MS; Chikarmane, S; Conant, EF; Eghtedari, M; Flanagan, MR; Hawley, J ...
Published in: J Natl Compr Canc Netw
September 2023

The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer Screening and Diagnosis Panel is composed of a multidisciplinary team of experts in the field, including representation from medical oncology, gynecologic oncology, surgical oncology, internal medicine, family practice, preventive medicine, pathology, diagnostic and interventional radiology, as well as patient advocacy. The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and discussion surrounding the most recent updates to the guideline's screening recommendations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

September 2023

Volume

21

Issue

9

Start / End Page

900 / 909

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Health Personnel
  • Female
  • Family Practice
  • Early Detection of Cancer
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bevers, T. B., Niell, B. L., Baker, J. L., Bennett, D. L., Bonaccio, E., Camp, M. S., … Stehman, K. (2023). NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J Natl Compr Canc Netw, 21(9), 900–909. https://doi.org/10.6004/jnccn.2023.0046
Bevers, Therese B., Bethany L. Niell, Jennifer L. Baker, Debbie L. Bennett, Ermelinda Bonaccio, Melissa S. Camp, Sona Chikarmane, et al. “NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.J Natl Compr Canc Netw 21, no. 9 (September 2023): 900–909. https://doi.org/10.6004/jnccn.2023.0046.
Bevers TB, Niell BL, Baker JL, Bennett DL, Bonaccio E, Camp MS, et al. NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J Natl Compr Canc Netw. 2023 Sep;21(9):900–9.
Bevers, Therese B., et al. “NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.J Natl Compr Canc Netw, vol. 21, no. 9, Sept. 2023, pp. 900–09. Pubmed, doi:10.6004/jnccn.2023.0046.
Bevers TB, Niell BL, Baker JL, Bennett DL, Bonaccio E, Camp MS, Chikarmane S, Conant EF, Eghtedari M, Flanagan MR, Hawley J, Helvie M, Hodgkiss L, Hoyt TL, Ivanovich J, Jochelson MS, Kulkarni S, Lancaster RB, Mauer C, Maxwell J, Patel BK, Pearlman M, Philpotts L, Plecha D, Plichta JK, Shakeri S, Smith ML, Streibert CL, Strigel RM, Tumyan L, Winkler NS, Wolverton DE, Bergman MA, Kumar R, Stehman K. NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J Natl Compr Canc Netw. 2023 Sep;21(9):900–909.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

September 2023

Volume

21

Issue

9

Start / End Page

900 / 909

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Medical Oncology
  • Humans
  • Health Personnel
  • Female
  • Family Practice
  • Early Detection of Cancer
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis